
Keywords: eGFR; estimated glomerular filtration rate; KIM-1; kidney injury molecule-1; NAG; N-acetyl-β-d-glucosaminidase; NGAL; neutrophil gelatinase-associated lipocalin; GC; gemcitabine and cisplatin; MVAC; methotrexate, vinblastine, doxorubicin, adiamycin, and